Dingzhou Li

756 total citations
33 papers, 473 citations indexed

About

Dingzhou Li is a scholar working on Cardiology and Cardiovascular Medicine, Computational Theory and Mathematics and Immunology. According to data from OpenAlex, Dingzhou Li has authored 33 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Computational Theory and Mathematics and 5 papers in Immunology. Recurrent topics in Dingzhou Li's work include Computational Drug Discovery Methods (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Statistical Methods in Clinical Trials (4 papers). Dingzhou Li is often cited by papers focused on Computational Drug Discovery Methods (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Statistical Methods in Clinical Trials (4 papers). Dingzhou Li collaborates with scholars based in United States, Switzerland and France. Dingzhou Li's co-authors include Michel Plotkine, Isabelle Margaill, Nicole Croci, Catherine Marchand‐Leroux, Roscoe L. Warner, Julia Kenny, Lina Luo, Jennifer Colangelo, Kent J. Johnson and Jiri Aubrecht and has published in prestigious journals such as PLoS ONE, American Journal Of Pathology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Dingzhou Li

30 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dingzhou Li United States 11 126 103 86 58 49 33 473
Sheng Deng China 17 279 2.2× 154 1.5× 99 1.2× 43 0.7× 44 0.9× 50 865
Ryoichi Nagata Japan 15 239 1.9× 285 2.8× 101 1.2× 65 1.1× 54 1.1× 73 999
Bing Yang China 16 214 1.7× 45 0.4× 101 1.2× 26 0.4× 28 0.6× 64 656
Lin Wu China 13 124 1.0× 38 0.4× 49 0.6× 19 0.3× 62 1.3× 46 452
Song Qiao China 14 229 1.8× 41 0.4× 84 1.0× 53 0.9× 21 0.4× 54 624
Mauricio Henríquez Chile 17 289 2.3× 46 0.4× 65 0.8× 40 0.7× 32 0.7× 32 615
Peicheng Li China 16 342 2.7× 46 0.4× 111 1.3× 119 2.1× 29 0.6× 31 761
Yuzhen Li China 14 324 2.6× 37 0.4× 103 1.2× 31 0.5× 52 1.1× 46 684
Zhenxing Zhang China 14 275 2.2× 21 0.2× 105 1.2× 43 0.7× 44 0.9× 23 573
Rui Hua China 8 377 3.0× 43 0.4× 98 1.1× 55 0.9× 50 1.0× 19 655

Countries citing papers authored by Dingzhou Li

Since Specialization
Citations

This map shows the geographic impact of Dingzhou Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingzhou Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingzhou Li more than expected).

Fields of papers citing papers by Dingzhou Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingzhou Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingzhou Li. The network helps show where Dingzhou Li may publish in the future.

Co-authorship network of co-authors of Dingzhou Li

This figure shows the co-authorship network connecting the top 25 collaborators of Dingzhou Li. A scholar is included among the top collaborators of Dingzhou Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingzhou Li. Dingzhou Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Dingzhou, et al.. (2024). Statistical applications of virtual control groups to nonrodent animal toxicity studies: An initial evaluation. Regulatory Toxicology and Pharmacology. 154. 105733–105733. 2 indexed citations
3.
Potter, David M., Thomas E. Bradstreet, Davit Sargsyan, et al.. (2024). The partnership between statisticians and the Institutional Animal Care and Use Committee (IACUC). Pharmaceutical Statistics. 24(1). e2390–e2390.
4.
Palazzi, Xavier, Armelle Grevot, Magali Guffroy, et al.. (2024). Points to consider regarding the use and implementation of virtual controls in nonclinical general toxicology studies. Regulatory Toxicology and Pharmacology. 150. 105632–105632. 8 indexed citations
5.
Rossman, Eric I., Todd Wisialowski, Hugo M. Vargas, et al.. (2023). Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As. Journal of Pharmacological and Toxicological Methods. 123. 107270–107270. 12 indexed citations
6.
Kilfoil, Peter J., Derek J. Leishman, Dingzhou Li, et al.. (2021). Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters. European Journal of Pharmacology. 912. 174584–174584. 9 indexed citations
7.
Opsahl, Alan, Dingzhou Li, Nicole Streiner, et al.. (2021). Characterizing Intra-Tumor and Inter-Tumor Variability of Immune Cell Infiltrates in Murine Syngeneic Tumors. American Journal Of Pathology. 191(12). 2133–2146. 2 indexed citations
8.
Li, Dingzhou, et al.. (2020). Nonclinical species sensitivity to convulsions: An IQ DruSafe consortium working group initiative. Journal of Pharmacological and Toxicological Methods. 103. 106683–106683. 8 indexed citations
9.
Li, Dingzhou, et al.. (2020). Reprint of: Nonclinical species sensitivity to convulsions: An IQ DruSafe consortium working group initiative. Journal of Pharmacological and Toxicological Methods. 105. 106919–106919. 2 indexed citations
10.
Luo, Lina, Jiri Aubrecht, Dingzhou Li, et al.. (2018). Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans. PLoS ONE. 13(3). e0193824–e0193824. 125 indexed citations
11.
Li, Dingzhou, et al.. (2016). Statistical power analysis of cardiovascular safety pharmacology studies in conscious rats. Journal of Pharmacological and Toxicological Methods. 81. 128–135. 7 indexed citations
12.
Whritenour, Jessica, et al.. (2013). Development and partial validation of a mouse model for predicting drug hypersensitivity reactions. Journal of Immunotoxicology. 11(2). 141–147. 9 indexed citations
13.
Sobol, Zhanna, Richard A. Spellman, Dingzhou Li, et al.. (2012). Development and validation of an in vitro micronucleus assay platform in TK6 cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 746(1). 29–34. 28 indexed citations
14.
Li, Dingzhou, et al.. (2008). Heartbeat dynamics in adrenergic blocker treated conscious beagle dogs. Journal of Pharmacological and Toxicological Methods. 58(2). 118–128. 5 indexed citations
15.
Li, Dingzhou, et al.. (2005). Seizure anticipation, states of consciousness and marginal predictability in temporal lobe epilepsy. Epilepsy Research. 68(1). 9–18. 4 indexed citations
16.
Li, Dingzhou, Isabelle Margaill, Bruno Palmier, et al.. (2003). LF 16‐0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia. British Journal of Pharmacology. 139(8). 1539–1547. 47 indexed citations
17.
18.
Li, Dingzhou, et al.. (2003). Linear and Nonlinear Measures and Seizure Anticipation in Temporal Lobe Epilepsy. Journal of Computational Neuroscience. 15(3). 335–345. 7 indexed citations
19.
Li, Dingzhou, Catherine Marchand‐Leroux, Nicole Croci, Michel Plotkine, & Isabelle Margaill. (2002). l-NAME reduces infarction, neurological deficit and blood–brain barrier disruption following cerebral ischemia in mice. European Journal of Pharmacology. 457(2-3). 137–146. 56 indexed citations
20.
Savit, Robert, et al.. (2001). Understanding Dynamic State Changes in Temporal Lobe Epilepsy. Journal of Clinical Neurophysiology. 18(3). 246–258. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheng Deng Breakdown of academic impact, for papers by Ryoichi Nagata Breakdown of academic impact, for papers by Bing Yang Breakdown of academic impact, for papers by Lin Wu Breakdown of academic impact, for papers by Song Qiao Breakdown of academic impact, for papers by Mauricio Henríquez Breakdown of academic impact, for papers by Peicheng Li Breakdown of academic impact, for papers by Yuzhen Li Breakdown of academic impact, for papers by Zhenxing Zhang Breakdown of academic impact, for papers by Rui Hua
Rankless by CCL
2026